Cargando…
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders
Totally implantable vascular access devices (TIVADs) are commonly used in conjunction with enzyme replacement therapy (ERT) for lysosomal storage disorders (LSDs). This case series describes potential complications associated with long-term TIVAD use, such as compromise of skin integrity, infection,...
Autores principales: | Hendriksz, Christian J., Harmatz, Paul, Giugliani, Roberto, Roberts, Jane, Arul, G. Suren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966583/ https://www.ncbi.nlm.nih.gov/pubmed/29845015 http://dx.doi.org/10.1016/j.ymgmr.2018.02.007 |
Ejemplares similares
-
The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience
por: McLoughlin, Mairead, et al.
Publicado: (2017) -
Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients
por: Giugliani, R., et al.
Publicado: (2017) -
Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014) -
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
por: Stepien, Karolina M., et al.
Publicado: (2020) -
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
por: Nathan, David G, et al.
Publicado: (2009)